TAK-593

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-593, covering 2010-04-27 to 2010-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer [Phase 1]